SCHEMBL21977094

SCHEMBL21977094

C/N=C(\C=C(/N)NC)Nc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAS2R38 P59533 3/20 0.40
▸ HSD17B10 Q99714 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ TP53 P04637 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ TYR P14679 1/20 0.40
▸ GRIN2D O15399 1/20 0.40
▸ GRIN3B O60391 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ GRIN1 Q05586 1/20 0.40
▸ GRIN2A Q12879 1/20 0.40
▸ GRIN2B Q13224 1/20 0.40
▸ GRIN2C Q14957 1/20 0.40
▸ GRIN3A Q8TCU5 1/20 0.40
▸ SIGMAR1 Q99720 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ GAA P10253 5/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3802208 0.76 TGM2 (0.52) TAS2R38HSD17B10ALDH1A1TP53TSHR
SCHEMBL3802207 0.76 TGM2 (0.52) TAS2R38HSD17B10ALDH1A1TP53TSHR
SCHEMBL1743266 0.70 HTR3E (0.61) TAS2R38HSD17B10ALDH1A1TP53TSHR
SCHEMBL14952315 0.70 HTR3E (0.61) TAS2R38HSD17B10ALDH1A1TP53TSHR
SCHEMBL13358496 0.70 HTR3E (0.61) TAS2R38HSD17B10ALDH1A1TP53TSHR
SCHEMBL3110483 0.68 ALDH1A1 (0.54) TAS2R38HSD17B10ALDH1A1TP53TSHR
SCHEMBL11184467 0.65 TAS2R38 (0.50) TAS2R38HSD17B10ALDH1A1TP53TSHR
SCHEMBL20627768 0.65 MAPT (0.46) TAS2R38HSD17B10ALDH1A1TP53TSHR
SCHEMBL14962067 0.65 MAPT (0.59) TAS2R38HSD17B10ALDH1A1TP53TSHR
SCHEMBL19233143 0.65 F2 (0.45) HSD17B10ALDH1A1TSHRLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3019480-B1 2,4- OR 4,6-DIAMINOPYRIMIDINE COMPOUNDS AS IDH2 MUTANTS INHIBITORS FOR THE TREATMENT OF CANCER AGIOS PHARMACEUTICALS INC (US) 2020-05-06 — — EP disclosed
Send feedback